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Abstract
Background: The Prolactin (PRL) hormone gene family shows considerable variation among placental
mammals. Whereas there is a single PRL gene in humans that is expressed by the pituitary, there are an
additional 22 genes in mice including the placental lactogens (PL) and Prolactin-related proteins (PLPs)
whose expression is limited to the placenta. To understand the regulation and potential functions of these
genes, we conducted a detailed temporal and spatial expression study in the placenta between embryonic
days 7.5 and E18.5 in three genetic strains.
Results: Of the 22 PRL/PL genes examined, only minor differences were observed among strains of mice.
We found that not one family member has the same expression pattern as another when both temporal
and spatial data were examined. There was also no correlation in expression between genes that were
most closely related or between adjacent genes in the PRL/PL locus. Bioinformatic analysis of upstream
regulatory regions identified conserved combinations (modules) of putative transcription factor binding
sites shared by genes expressed in the same trophoblast subtype, supporting the notion that local
regulatory elements, rather than locus control regions, specify subtype-specific expression. Further
diversification in expression was also detected as splice variants for several genes.
Conclusion: In the present study, a detailed temporal and spatial placental expression map was generated
for all murine PRL/PL family members from E7.5 to E18.5 of gestation in three genetic strains. This detailed
analysis uncovered several new markers for some trophoblast cell types that will be useful for future
analysis of placental structure in mutant mice with placental phenotypes. More importantly, several main
conclusions about regulation of the locus are apparent. First, no two family members have the same
expression pattern when both temporal and spatial data are examined. Second, most genes are expressed
in multiple trophoblast cell subtypes though none were detected in the chorion, where trophoblast stem
cells reside, or in syncytiotrophoblast of the labyrinth layer. Third, bioinformatic comparisons of upstream
regulatory regions identified predicted transcription factor binding site modules that are shared by genes
expressed in the same trophoblast subtype. Fourth, further diversification of gene products from the PRL/
PL locus occurs through alternative splice isoforms for several genes.
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Background
The closely related Prolactin (PRL) and growth hormone
genes are thought to have arisen from a common ancestral
gene as a result of gene duplication and subsequent diver-
gence early in vertebrate evolution [1]. Further gene dupli-
cations have given rise to expanded growth hormone or
PRL clusters in a species-specific manner. Primates, for
example, have an expanded growth hormone locus (con-
taining five genes in close proximity on Ch 17) but a sin-
gle PRL gene. In contrast, rodents have a single growth
hormone gene but an amplified PRL locus containing 23
PRL-like genes in mice [2-4] and at least 25 in the rat [5],
all located in close proximity in a single locus. While
many of the genes in the mouse and rat PRL family are
orthologues, some are specific to either species indicating
gene duplications since the divergence of mice and rats.
Amplification of the PRL gene appears to have happened
independently at least twice in mammals as ruminants
have an expanded PRL  locus whose members are not
orthologous to those of the rodent PRL family [3,6-8].
The PRL family consists of 23 closely related genes in mice
found within a one megabase locus on chromosome 13
[2-4]. PRL was originally identified as a pituitary hormone
involved in mammary gland development [9] but is now
understood to have a wide range of biological actions and
targets. PRL is of particular importance for female repro-
duction and mice harboring null mutations in the PRL or
PRL receptor genes have deficits in ovarian hormone pro-
duction, decidualization, pup-induced maternal behavior
and other adaptations to pregnancy [10-12]. The mamma-
lian placenta is an important endocrine organ coordinat-
ing maternal and fetal responses to pregnancy and is a
source of extrapituitary lactogenic activity as it produces
several lactogenic PRL-related proteins. The first PRL-
related proteins were discovered in rodents and called Pla-
cental Lactogen I and II (PL-I and PL-II) based on their lac-
togenic effects. With molecular cloning and genome
sequencing, the family has grown to include at least three
genes encoding PL-I proteins in mice plus many other
more distantly related genes, although not all family
members are lactogenic. All of the PRL/PL-related genes
are expressed at the fetal maternal interface, predomi-
nantly in cells of the trophoblast lineage [3,4]. The
nomenclature of the PRL/PL  genes has recently been
revised [13] and the new nomenclature will be used
throughout the paper (see Table 1).
The Placental Lactogen proteins (now called Prl3b  and
Prl3d) bind to the PRL receptor and mimic the actions of
pituitary PRL [14], which include multiple pregnancy-
dependent processes such as mammary gland develop-
ment, corpus luteum function [15], maternal behavior
[16] and pancreas function [17]. However, the additional
Table 1: Standardized nomenclature for the mouse PRL/PL family
PRL Family Gene Name Official Symbol Official Alias Symbol Mouse Genbank Accession No.
Prolactin Prl Prl1a1 NM_011164
Prolactin family 2, subfamily a, member 1 Prl2a1 PLP-M NM_019991
Prolactin family 2, subfamily b, member 1 Prl2b1 PLP-K NM_025532
Prolactin family 2, subfamily c, member 2 Prl2c2 PLF1 NM_031191
Prolactin family 2, subfamily c, member 3 Prl2c3 PLF2 K03235
Prolactin family 2, subfamily c, member 4 Prl2c4 MRP3 NM_011954
Prolactin family 2, subfamily c, member 5 Prl2c5 MRP4 AF128884
Prolactin family 3, subfamily a, member 1 Prl3a1 PLP-I AF525154
Prolactin family 3, subfamily b, member 1 Prl3b1 PL-II, Csh2 M14647
Prolactin family 3, subfamily c, member 1 Prl3c1 PLP-J NM_013766
Prolactin family 3, subfamily d, member 1 Prl3d1 PL-Iα, Csh1α AF525162
Prolactin family 3, subfamily d, member 2 Prl3d2 PL-Iβ, Csh1β NM_172155
Prolactin family 3, subfamily d, member 3 Prl3d3 PL-Iγ, Csh1γ NM_172156
Prolactin family 4, subfamily a, member 1 Prl4a1 PLP-A NM_011165
Prolactin family 5, subfamily a, member 1 Prl5a1 PLP-L NM_023746
Prolactin family 6, subfamily a, member 1 Prl6a1 PLP-B NM_011166
Prolactin family 7, subfamily a, member 1 Prl7a1 PLP-E NM_008930
Prolactin family 7, subfamily a, member 2 Prl7a2 PLP-F NM_011168
Prolactin family 7, subfamily b, member 1 Prl7b1 PLP-N AF525156
Prolactin family 7, subfamily c, member 1 Prl7c1 PLP-O NM_026206
Prolactin family 7, subfamily d, member 1 Prl7d1 PLF-RP NM_011120
Prolactin family 8, subfamily a, member 1 Prl8a1 PLP-Cδ NM_028477
Prolactin family 8, subfamily a, member 2 Prl8a2 dPRP NM_010088
Prolactin family 8, subfamily a, member 6 Prl8a6 PLP-Cα NM_011167
Prolactin family 8, subfamily a, member 8 Prl8a8 PLP-Cγ NM_023741
Prolactin family 8, subfamily a, member 9 Prl8a9 PLP-Cβ NM_023332BMC Genomics 2008, 9:352 http://www.biomedcentral.com/1471-2164/9/352
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PRL/PL-related proteins are 'non-classical' members of the
PRL family as they do not bind and activate the PRL recep-
tor, although receptor-binding activity for several mem-
bers has not yet been investigated. Overall, the biological
targets and functions are known for only a few of the PRL/
PL-related proteins. Prl2c (Proliferin) [18] and Prl7d1
(Proliferin-related protein) [19] have angiogenic and anti-
angiogenic effects on endothelial cells, respectively [20].
Prl7a1 (PLP-E) and Prl7a2 (PLP-F) promote blood cell
production [21,22]. Prl4a1 (PLP-A) suppresses natural
killer cells [23]. The only mouse mutants that have been
reported so far are for Prl4a1 [24] and Prl8a2 (dPRP) [25].
Neither mouse mutant shows an obvious phenotype
under normal conditions but embryonic lethality ensues
when pregnant mice are exposed to hypoxia. This implies
either that the PRL/PL-related genes have evolved to
respond to physiological stress or alternatively that redun-
dancy within the gene family minimizes the effects of sin-
gle gene mutations.
The human growth hormone locus relies on a locus con-
trol region 15–32 kilobases upstream to drive tissue-spe-
cific expression [26,27]. Within the PRL/PL  locus in
rodents, however, there is no evidence so far for similar
control of regulation and no correlation between gene
location within the PRL/PL locus and temporal or spatial
expression patterns within the placenta has been observed
[4]. Placental expression data for most of the murine PRL
family members has been reported [4,25,28-34],
although almost exclusively at mid-gestation, and com-
prehensive temporal and spatial expression data for all 23
members of the PRL/PL family has not yet been compiled.
We have recently expanded on trophoblast cell type clas-
sifications within the murine placenta [35]. Our objective
here was to generate a high-resolution map of PRL/PL
expression patterns and explore associations between co-
expressed genes and their respective positions within the
locus and/or similarities in regulatory elements.
Methods
cDNA probes
cDNAs with the full length open reading frames for each
PRL/PL family member were used as probes for northern
blot and in situ hybridization. cDNAs for Prl3b1, Prl2c1,
Prl7d1 were kindly provided by Dr. J. Rossant. cDNAs for
Prl3d1, Prl8a2, Prl4a1, Prl6a1, Prl7a1, Prl3c1, Prl5a1 were
kindly provided by Dr. D. Linzer. cDNAs for Prl8a9,
Prl8a8, Prl3a1, Prl2b1, Prl2a1, Prl7b1, Prl7c1 were kindly
provided by Dr. M. Soares. Full length cDNAs for Prl,
Prl8a6, Prl8a1, Prl7a2, and Pcdh12 were generated by PCR:
Prl (forward 5'-CTCTCAGGCCATCTTGGAGA-3', reverse
5'-TAAGCAGTTGTTTTGATGGGC-3); Prl8a6 (forward 5'-
ACGATGGCACTGCTATTGAGT-3', reverse 5'-TGGAG-
CATTTTCAAAGCAGA-3'); Prl8a1 (forward 5'-CAAAGAT-
GGTGCTGCCATTA-3', reverse 5'-CCCAGTTATGCGA
CATTTCA-3');  Prl7a2  (forward 5'-GCCAGAACTCTTCA-
GAGATGTC-3', reverse 5'-TTAAGCATCATGAAGCATCTC
T3');  Pcdh12  (forward 5'-CAATGGGAATCCCCCTAAGT-
3', reverse 5'-TAGGTGGTCCACACTGGTGA-3'). PCR frag-
ments were cloned into pGEM-T easy (Promega) and
sequence verified.
PCR primers and conditions
RT-PCR was used to determine whether predicted iso-
forms of Prl6a1, Prl8a6, Prl8a8, Prl8a1, and Prl7a1 were
expressed in vivo. RNA was isolated from implantation
sites or placentas at various stages of gestation by using
Trizol (Invitrogen) according to the manufacturer's
instructions. cDNA synthesis employed oligo dT primer
and superscript enzyme (Invitrogen) according to the
manufacturer's instructions. PCR primer sets and condi-
tions are listed in Table 2. All PCR amplicons were cloned
into pGEM-T easy (Promega) and sequence verified.
Phylogenetic analysis and transcription factor binding site 
analysis
cDNA sequences of the 23 paralogous PRL/PL  family
members were input into the Mega 3.1 software program
to generate a phylogenetic tree [36]. Three kilobases of
upstream promoter regions of paralogous PRL/PL family
members were analyzed for transcription factor binding
sites by using the Toucan 2 software program [37].
Northern blot analysis
Northern blot analysis was performed as previously
described [35]. Briefly, RNA was extracted by using Trizol
(Invitrogen), separated on a 1.1% formaldehyde gel and
transferred to nylon membranes (Perkin Elmer). After UV
cross-linking, the membranes were hybridized in Church
buffer [38] containing 32P-labeled cDNA probes. An 18S
ribosomal RNA probe was used to check for RNA integrity
and standardize for gel loading.
In situ hybridization
Placentae were dissected in cold phosphate buffered
saline (PBS) and fixed overnight in 4% paraformaldehyde
in PBS at 4°C. After rinsing in PBS, tissues were processed
through sucrose gradients (10% in PBS and 25% in PBS)
before being embedded in OCT (Tissue Tek). Ten μm sec-
tions were cut and mounted on Super Frost Plus slides
(VWR) and stored at -80°C. For in situ hybridization, sec-
tions were re-hydrated in PBS, post-fixed in 4% parafor-
maldehyde for 10 minutes, treated with proteinase K (30
μg/ml) for 10 minutes at room temperature, acetylated for
10 minutes (acetic anhydride, 0.25%; Sigma) and hybrid-
ized with digoxigenin-labeled probes overnight at 65°C.
Digoxigenin labeling was done according to the manufac-
turers instructions (Roche). Hybridization buffer con-
tained 1× salts (200 mM sodium choride, 13 mM tris, 5
mM sodium phosphate monobasic, 5 mM sodium phos-BMC Genomics 2008, 9:352 http://www.biomedcentral.com/1471-2164/9/352
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phate dibasic, 5 mM EDTA), 50% formamide, 10% dex-
tran sulfate, 1 mg/ml yeast tRNA (Roche), 1× Denhardt's
(1% w/v bovine serum albumin, 1% w/v Ficoll, 1% w/v
polyvinylpyrrolidone), and DIG-labeled probe (final
dilution of 1:2000 from reaction with 1 μg template
DNA). Two 65°C post-hybridization washes (1× SSC,
50% formamide, 0.1% tween-20) followed by two room
temperature washes in 1× MABT (150 mM sodium chlo-
ride, 100 mM maleic acid, 0.1% tween-20, pH7.5) were
followed by 30 minutes RNAse treatment (400 mM
sodium chloride, 10 mM tris pH7.5, 5 mM EDTA, 20 μg/
ml RNAse A). Sections were blocked in 1× MABT, 2%
blocking reagent (Roche), 20% heat inactivated goat
serum for 1 hour and incubated overnight in block with
anti-DIG antibody (Roche) at a 1:2500 dilution at 4°C.
After four 20 minute washes in 1× MABT, slides were
rinsed in 1× NTMT (100 mM NaCl, 50 mM MgCl, 100
mM tris pH 9.5, 0.1% tween-20) and incubated in NBT/
BCIP in NTMT according to the manufacturers instruc-
tions (Promega). Slides were counterstained with nuclear
fast red, dehydrated and cleared in xylene and mounted in
cytoseal mounting medium (VWR).
For double labeled in situ hybridizations, a fluorescein-
labeled probe was generated following the manufacturers
instructions (Roche) and added to the hybridization mix
along with the DIG-labeled probe. Following NBT/BCIP
development of the first probe, the antibody-enzyme con-
jugate was inactivated by 30 min incubation in 1× MABT
at 65°C, followed by 30 min in 0.1 M glycine pH 2.2 at
room temperature. The slides were then blocked again in
1× MABT, 2% blocking reagent (Roche), 20% heat inacti-
vated goat serum for 1 hour and incubated overnight in
block with anti-Fluorescein antibody (Roche) at a 1:2500
dilution at 4°C. The second signal was developed as pre-
viously described but one modification, the substrate
INT/BCIP (Roche), producing a brown colour, was used
in place of NBT/BCIP. As the INT/BCIP is soluble in alco-
hols and xylene, slides were counterstained with nuclear
fast red and mounted directly under Crystal Mount Aque-
ous Mounting Medium (Sigma).
Results
PRL/PL Family Nomenclature and Expression Analysis
A revised system for naming members of the mouse and
rat PRL/PL gene families has recently been introduced [13]
and is used throughout (see Table 1). Our analysis was
aimed at being able to discriminate the patterns of expres-
sion of all 23 genes in the PRL/PL locus. However, the sim-
ilarity of some family members precluded us form being
able to do this for both spatial and temporal analysis. For
example, the new nomenclature cites four additional
murine Prl2c (Proliferin) genes (Prl2c2, Prl2c3, Prl2c4, and
Prl2c5) since four cDNAs have been reported, but the
actual number of genes and their respective locations
within the genome remain a matter of debate. Differenti-
ation among the various Prl2c cDNAs requires RT-PCR
analysis followed by restriction enzyme digestion of the
resultant amplicons [39-41]. Therefore, as the methodol-
ogy used in the current study (cDNA probe for Prl2c1 used
in northern blot analysis and in situ hybridization) could
not discriminate expression from the various Prl2c genes
or isoforms, hypothesized or annotated, the data for all
genes was summarized as Prl2c. Similarly, data for Prl3d1,
Table 2: Primers and conditions for isoform-specific PCR analysis
PCR Primer Name Primer Sequence PCR Conditions
Prl6a1 forward 5'-GGTCATTTCCCAGATGCTGT-3' 1.5 mM MgCl2, 35 cycles, 60°C annealing
Prl6a1 common reverse 5'-GGGCTCCCTCCTTAGACACT-3'
Prl6a1 novel forward 5'-GCCTGAGAAGGCAAAGAAAA-3
Prl8a6 forward 5'-CTGCCATTCAAGTCTCACGA-3' 1.5 mM MgCl2, 30 cycles, 60°C annealing (Novel forward rxn – 35 cycles)
Prl8a6 common reverse 5'-CTCAAAAGCCAAGGAGATCG-3'
Prl8a6 novel forward 5'-GCTCGATTATATAGGAACAGGAA-3'
Prl8a8 forward 5'-GAAAAAGAATTGTGATT-3' 2.0 mM MgCl2, 35 cycles, 46°C annealing (Novel forward rxn – 1.5 mM 
MgCl2)
Prl8a8 common reverse 5'-TCAATAGTTATGTATTGAA-3'
Prl8a8 novel forward 5'-ATAACTCCGATGAAGC-3'
Prl8a1 reverse 5'-CCAAACAATCAACTGCCATG-3' 1.5 mM MgCl2, 30 cycles, 60°C annealing
Prl8a1 common forward 5'-AACCCCACTTCTGCACATTC-3'
Prl8a1 novel reverse 5'-CCCAAAAGATCGACCCATAA-3'
Prl7a1 reverse 5'-TCAGCCACATTTTCTGTTGC-3' 2.0 mM MgCl2, 28 cycles, 60°C annealing (Novel reverse rxn 32 cycles)
Prl7a1 common forward 5'-AAGGGACTGTTGGATCATGC-3'
Prl7a1 novel reverse 5'-TGGCATTCATGAGTGAGAAA-3'BMC Genomics 2008, 9:352 http://www.biomedcentral.com/1471-2164/9/352
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Prl3d2  and Prl3d3  (Placental Lactogen I alpha,  beta  and
gamma) are summarized as Prl3d.
In situ hybridization was used to define the spatial pat-
terns of expression between embryonic days (E) 8.5 and
18.5 (term gestation). The various trophoblast cell types
in the mouse placenta are shown in Figure 1 for reference.
In general, the fully developed placenta has distinct layers:
a maternal decidual zone which also contains spiral
artery-associated trophoblast giant cells (TGC) and glyco-
gen trophoblast cells that invade into it; a junctional zone
consisting of parietal TGCs, spongiotrophoblast cells and
glycogen trophoblast cells; and finally the labyrinth, in
which TGCs line maternal blood canals that enter the lab-
yrinth leading into small sinusoids lined by sinusoidal
TGCs and syncytiotrophoblast cells (Fig 1) [35,42,43].
Northern blotting of whole placental tissue was used to
confirm the specificity of the cDNA probes and to assess
temporal expression. Analysis was performed in three
commonly used mouse strain backgrounds (CD1
(Charles River) or Swiss, C57/B6, 129 svj), which are
independently derived strains, to explore possible varia-
tion.
Expression Profiles for PRL/PL Family Members 
Throughout Placental Development
The summary of northern blot and in situ hybridization
analysis is shown in Figure 2 and Additional file 1, and the
detailed data for each gene is presented in Additional files
2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19,
20, 21, (see additional files 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12,
13, 14, 15, 16, 17, 18, 19, 20, 21). Prl1a1 (Prl) expression
was not detected in the placenta whereas all of the other
genes were, in distinct patterns. The expression patterns
were generally consistent across the three strains and data
are shown for the CD1 background. However, a subset of
PRL/PL-related genes displayed subtle variations by strain,
either in the timing of the onset/offset of expression
within a particular trophoblast subtype or in the number
of cells of a given subtype that express the PRL family
member. These small differences are outlined in Addi-
tional files 3, 11, 16 and 20. Unexpected and unpublished
expression patterns were also noted, particularly the
expression of many PRL/PL genes in the developing ecto-
placental cone (see below) and the segregation of certain
family members to the spongiotrophoblast or glycogen
cell populations within the junctional zone (discussed
below). Interestingly, not one PRL/PL gene was expressed
in the chorion early in placental development or in the
syncytiotrophoblast cells of the mature labyrinth.
In general, because of the inclusion of numerous gesta-
tional time points and detailed spatial analysis, our anal-
ysis generated new expression information for all family
members. However, three family members showed dis-
crepancies with previously published data. Prl3c1 (Prolac-
tin-like protein J) is expressed in the antimesometrial
decidua early in pregnancy and lasts as long as the antime-
sometrial decidual tissue persists [25,31]. In the current
study, Prl3c1 expression was also detected in the mesome-
trial decidua, although to a lesser extent, and in spongio-
trophoblast at mid-gestation (see Additional file 3).
Prl8a1 (Prolactin-like protein C delta) expression was not
detected in the migratory glycogen trophoblast cells at
mid-gestation (see Additional file 12), or as strongly in
the spongiotrophoblast cells compared to a previous
report [4]. Finally, Prl7c1 (Prolactin-like protein O) has
been reported to be expressed in spongiotrophoblast,
TGCs and the labyrinth [4] but in the present study Prl7c1
expression was detected in the ectoplacental cone early in
gestation and was then restricted to glycogen trophoblast
cells later in gestation, although by E12.5 expression was
very much reduced (see Additional file 17). Some of these
differences could be explained by differences in the use of
in situ hybridization compared with immunohistochem-
istry or with the use of different in situ hybridization
probes or sensitivity, but the significant discrepancy
regarding Prl7c1 expression is more difficult to reconcile.
We have re-sequenced all of our cDNA plasmids to con-
firm that we used the correct probes.
No Correlation Between the Spatial/Temporal Expression 
Profiles of PRL/PL Family Members and their Position 
within the Locus or Sequence Similarity
In comparing the expression profiles of the genes in the
PRL/PL  locus, each gene had a largely unique pattern
when considering both spatial and temporal expression.
By aligning the expression patterns with an evolutionary
tree based on gene sequence similarity (Fig. 2B) or with
position along the locus (see Additional file 1), it was
clear that there were no obvious patterns. This was true
regardless of the phylogenetic methodology applied or
the nature of the comparison (cDNA versus amino acid
sequence).
Expression of Numerous Prolactin Family Members within 
the Ectoplacental Cone
An unexpected finding was that expression of at least half
of the PRL/PL family members was detected within the
ectoplacental cone at E8.5 (Figs 2 and 3). Prl3d1, Prl2c,
Prl7a1 (not shown, same pattern as Prl3d1, see Additional
file 14), Prl4a1, Prl8a9, Prl8a1 and Prl5a1 were detectable
in parietal TGCs at the periphery of the ectoplacental cone
at E8.5, although not all were uniformly expressed in all
parietal TGC (Fig 3). Only Prl3d and Prl7a1 were truly
restricted to the parietal TGC subtype however, as Prl2c,
Prl4a1, Prl8a1 and Prl5a1 were also expressed with the
core of the EPC (Fig 3). In contrast, expression of Prl3b1,
Prl7d1, Prl6a1, Prl2a1, Prl7b1  and Prl7c1  were detected
within the centre of the ectoplacental cone and not inBMC Genomics 2008, 9:352 http://www.biomedcentral.com/1471-2164/9/352
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Figure 1
Placental anatomy and trophoblast subtypes at early and mid-gestation. A, B. Embryonic day 8.5 implantation site. A 
– The collapse of the ectoplacental cone cavity (~E8.0) brings the base of the ectoplacental cone into contact with the distal 
surface of the chorion, while the allantois makes contact with, and adheres to, the basal surface of the chorion by E8.5. B – 
Large parietal TGC cells line the implantationsite. C-H. Embryonic day 14.5 placenta. C – Spiral artery lined by spiral artery 
TGCs. D – parietal TGC with glycogen trophoblast cells located beneath within the spongiotrophoblast layer as well as glyco-
gen trophoblast cells which have invaded above the parietal TGC layer into the decidua. E – Clusters of glycogen trophoblast 
cells within the spongiotrophoblastlayer. F – Large central canal lined by canal TGCs. G – The maternal blood sinuses and fetal 
blood vessels (lined by endothelial cells) of the labyrinth are separated by a trilaminar trophoblast layer; sinusoidal TGCs that 
line the maternal sinusoids and two layers of syncytiotrophoblast. H – Clusters of glycogen trophoblast cells invade into the 
decidua beginning on E12.5. Ch – chorion, C-TGC – canal trophoblast giant cell, Dec – decidua, EPC – ectoplacental cone, 
Endo – endothelial cell, GlyT – glycogen trophoblast cell, P-TGC – parietal trophoblast giant cell, S-TGC – sinusoidal trophob-
last giant cell, SpA-TGC – spiral-associated trophoblast giant cell, SpT – spongiotrophoblast, SynT – syncytiotrophoblast cell (I 
– layer I, II- layer II). Black bar represents 0.1 mm.
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parietal TGCs (Fig 3). Again, however, not all the expres-
sion patterns within the ectoplacental cone appeared to be
uniform or similar to each other.
Glycogen Trophoblast or Spongiotrophoblast-Specific 
Expression
We detected expression of several PRL/PL-related genes in
the junctional zone of the placenta that contains spongio-
trophoblast and glycogen trophoblast cells. Expression of
the protocadherin gene, Pcdh12, has been shown to be
specific to trophoblast glycogen cells in the murine pla-
centa [44,45]. Therefore, Pcdh12 was used as a probe for
double in situ hybridization analysis to assess whether
PRL/PL family members expressed in the junctional zone
were specific to spongiotrophoblast or to glycogen tro-
phoblast cells (Fig 4). Surprisingly, most PRL/PL-related
genes that were expressed within the junctional zone were
either specifically expressed in spongiotrophoblast cells or
in glycogen trophoblast cells (Fig 4), not in both popula-
tions as is the case for Tpbpa  [46], a very widely used
marker for these two cell types. Prl3b1,  Prl2c,  Prl8a6,
Prl8a8, Prl8a1, Prl7a2, Prl3a1, Prl2b1, and Prl5a1 had com-
plementary expression patterns to Pcdh12, indicating
spongiotrophoblast cell specificity (Fig. 3). Prl6a1, Prl2a1,
Prl7b1 and Prl7c1 all had expression patterns overlapping
with Pcdh12 (or complementary to Prl7a2 or Prl8a8 as
shown) indicating they were specifically expressed in gly-
cogen trophoblast cells. The Prl4a1,  Prl8a9  and  Prl7d1
genes were expressed in both spongiotrophoblast and gly-
cogen trophoblast cells (Fig. 4). Importantly, though, not
all cells of a given subtype were positive for each gene. For
example, only a small proportion of spongiotrophoblast
and glycogen trophoblast cells were positive for Prl4a1, a
gene more highly expressed in TGCs. Prl6a1 and Prl7b1
were both expressed in glycogen trophoblast cells specifi-
cally, but Prl6a1 was more prevalent in glycogen trophob-
last cells that were resident within the junctional zone and
less abundantly expressed in migrating glycogen cells
located within the decidua. In contrast, Prl7b1 was more
abundantly expressed in migratory glycogen trophoblast
and spiral artery-associated TGCs throughout gestation.
Common Regulatory Modules Within Unique Gene 
Promoter Regions Likely Convey Trophoblast Subtype-
Specific Gene Expression
A major aim of the current study was to gain insights into
the transcriptional regulation of PRL/PL-related genes in
the murine placenta. Despite a significantly expanded res-
olution of PRL/PL family member expression, our data set
did not show any correlation between the expression pat-
terns of genes and their proximity to one another within
the locus, or between those most evolutionarily related.
This is consistent with previously published studies [2,4]
and bolsters the notion that local regulatory regions con-
vey trophoblast subtype- and temporal-specific expres-
sion rather than locus control regions. We then used the
Toucan2 bioinformatics program [37] to examine the
upstream regulatory regions (~3000 nt) of genes co-
expressed within trophoblast subtypes in an attempt to
identify conserved groups, or modules, of putative tran-
scription factor binding sites involved in subtype-specific
expression. Genes robustly expressed in glycogen tro-
phoblast cells (Prl6a1, Prl2a1, Prl7b1, Prl7c1, Prl8a9) were
analyzed for modules of transcription factor binding sites
that occur in all five promoter regions. Two modules were
identified, each containing putative binding sites for five
transcription factors within a region of ~600 base pairs
(Fig. 5A). The two modules both contained sites for AP1,
PRRX2, GATA3 and NKX3A. One of the modules also con-
tained a GFI1 site whereas the other contained a FOXJ2
site. We also examined the promoters of three genes co-
expressed in the sinusoidal TGC population (Prl3b1,
Prl2b1, Prl7d1) and detected two conserved modules (Fig.
5B). Both modules contained sites for GATA3 and SOX9.
Multiple Splice Variants for Some PRL/PL Family Members
The mouse genome sequence assemblies from the
Ensembl [47] (m36-Jun2006) and Vega [48] (v19-
Jun2006) databases predict the existence of splice variants
for several PRL/PL family members, including Prl6a1,
Prl8a6, Prl8a8, Prl8a1 and Prl7a1. In an effort to determine
whether the predicted isoforms were expressed in vivo,
sequences unique to each variant cDNA were used both to
search EST databases and for primer design for RT-PCR
analysis and cDNA sequencing.
Prl6a1
Use of an alternative exon 1 was predicted both in the
Ensembl assembly (transcript ENSMUST00000091679)
and by the Vega database (named Prl6a1-002) (Fig. 6).
Blast searches [49] using the predicted novel exon 1
sequence did not match any EST sequences in the NCBI or
the institute for genomic research (TIGR) [50] databases.
In addition, RT-PCR amplification using a forward primer
specific to the alternative exon 1 and a common reverse
primer recognizing exon 3 did not yield any bands,
despite using cDNA generated from all stages of placental
development and from three different genetic back-
grounds (Fig. 6).
Prl8a6
The novel splice variant of Prl8a6, predicted by both the
Ensembl (transcript ENSMUST00000080762) and Vega
(Prl8a6-001) genome assemblies, has a unique 5' untrans-
lated region (UTR) and an absence of exon 4 (Fig. 6). EST
database searches using the predicted cDNA identified an
EST from a placental cDNA library that was a perfect
match (accession AK005478), suggesting that this isoform
is expressed in vivo. RT-PCR analysis using primers flank-
ing exon 4 produced two amplicons (Fig. 6) and sequenc-BMC Genomics 2008, 9:352 http://www.biomedcentral.com/1471-2164/9/352
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ing of the PCR products revealed that the major upper
band contained exon 4 and the lower band did not con-
tain exon 4. Database searches revealed numerous ESTs
that contained the novel 5' UTR sequence but were not
missing exon 4. Since the entire published 5' UTR (tran-
script ENSMUST00000018392) is contained within pre-
dicted novel 5' UTR (ENSMUST00000080762), it is
possible that the novel 5' UTR is not unique but reflects
the incomplete 5' sequencing of ESTs in the databases cor-
responding to Prl8a6. However, RT-PCR analysis using a
forward primer specific to the predicted 5' UTR of
ENSMUST00000080762 produced a fragment which was
expressed only at E14.5 and not at E9.5, suggesting that
the novel 5' UTR sequence could be isoform specific (data
not shown).
Prl8a8
Originally annotated and confirmed as a six exon gene,
Ensembl and Vega assemblies both predict an additional
isoform of Prl8a8 containing a novel exon between exons
1 and 2 (transcript ENSMUST00000018016) (Fig 6).
NCBI database searches indicated 3 ESTs that contained
the novel exon (accession CK022447, CK032606,
CK020277) as well as over 33 ESTs that did not. The novel
isoform had already been submitted to Genbank as Prl8a8
isoform2  (accession AF230923). RT-PCR analysis and
sequencing of the PCR products confirmed expression of
both isoforms in E14.5 placenta (Fig 6).
Prl8a1
An alternative isoform of Prl8a1 was predicted by both
Ensembl (transcript ENSMUST00000095926) and Vega
to terminate with an extended exon 5 rather than with
exon 6, as is the case for the originally reported Prl8a1
(transcript ENSMUST00000006664) (Fig. 6). Searches of
the NCBI and TIGR EST databases revealed an EST that
was a 100% match with the predicted Prl8a1 novel iso-
form (accession AK014414). Our RT-PCR analysis indi-
cated that both isoforms are expressed at E9.5 and E14.5,
although similar to Prl8a8, the novel isoform is expressed
at a lower level (Fig. 6).
Prl7a1
An alternative isoform of Prl7a1  was predicted by the
Ensembl assembly (transcript ENSMUST00000095924)
to terminate with an extended exon 6 rather than with
exon 7, as is the case for the originally reported Prl7a1
(transcript ENSMUST00000006659) (Fig. 6). An EST
search returned a match with the novel isoform (accession
AK028371). In addition, RT-PCR using primers specific to
either the extended exon 6 or to exon 7, coupled with a
common forward primer for exon2, could amplify tran-
scripts from both isoforms (confirmed by sequencing) at
E9.5 and E14.5 (Fig. 6).
Multiple Prl2c Genes Exist, Located Both Inside and 
Outside the PRL/PL Family Locus
Between four and six Prl2c genes are predicted to exist
within the mouse genome [51,52]. Four unique cDNAs
Temporal and spatial expression profiles of PRL/PL family  members compared with phylogenetic tree analysis Figure 2
Temporal and spatial expression profiles of PRL/PL 
family members compared with phylogenetic tree 
analysis. A – Scale diagram of the PRL/PL gene locus on 
chromosome 13. Rectangles indicate the location of PRL 
family member genes and ovals represent the location of 
pseudogenes within the locus. Red arrows indicate the orien-
tation of each gene within the cluster. Note the large inver-
sion from Prl2b1 to Prl7c1. In addition, three Prl2c genes are 
located approximately 14 Mb upstream of the PRL/PL locus 
on chromosome 13. *The Prl2c gene located within the main 
prolactin family cluster (27–28 Mb) does not correspond to 
any of the 4 Prl2c genes previously annotated from cDNA 
sequences (Prl2c2-5) and is therefore referred to as Plf, the 
original gene symbol. B – Phylogenetic tree depicting the 
evolutionary relationship between the members of the PRL 
family coupled with temporal (northern blot analysis) and 
spatial (in situ hybridization summary) expression data for 
each gene. Blue boxes indicate some positive expression 
within the trophoblast subtype population while white boxes 
represent an absence of gene expression. **As the differ-
ences between the Prl2c genes (Prl2c2-5) cannot be discerned 
by northern blot analysis, the results in the current analysis 
reflect the combined expression of all these genes, and is 
therefore labeled simply as Prl2c.
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have been described [40,41,52], which correspond to the
four  Prl2c  genes currently annotated in the mouse
genome: Prl2c2, Prl2c3, Prl2c4 and Prl2c5. Notably, all of
these four genes are located outside of the main PRL/PL
locus but are still on chromosome 13. Three of the genes
are located approximately 10 Mb away from the main
PRL/PL locus; Prl2c4 is found at 12.88 Mb, Prl2c2 (MRP-
1/Plf-1)  i s  f o u n d  a t  1 3 . 0 9  M b  a n d  Prl2c5  (Formerly
Mrpplf4, MRP-4 and Plf-4) at 13.27 Mb (Fig 2), represent-
ing a Prl2c cluster outside the boundaries of the main PRL/
PL  locus. Some discrepancies and confusion remain
regarding the Prl2c  genes, however, as searches of
Ensembl show that Prl2c3 is listed as an alternative name
for Prl2c4 (also formerly Mrpplf3, MRP-2, Plf-2 and Plf-3).
Originally, detailed mapping of the mouse PRL/PL locus
[2,4] had identified only a single Prl2c  gene located
between Prl2a1 and Prl4a1 within the PRL/PL cluster on
chromosome 13. Only a single gene was identified in the
rat PRL/PL cluster also [5]. Indeed, a candidate Prl2c gene
exists in this location in mice (ENSMUSG00000062551)
and is currently predicted to have several alternative splice
variants. Interestingly, to our knowledge, cDNAs corre-
sponding to these predicted transcripts have yet to be
described. Overall, it is very likely that the nomenclature
will have to be revised as the existence of additional Prl2c
genes located inside and/or outside of the PRL/PL locus is
verified.
Discussion
In the present study, a detailed temporal and spatial pla-
cental expression map was generated for all murine PRL/
PL family members from E7.5 to E18.5 of gestation in
three genetic strains. This detailed analysis uncovered sev-
eral new markers for some trophoblast cell types that will
be useful for future analysis of placental structure in
mutant mice with placental phenotypes. Moreover, sev-
eral important conclusions about regulation of the locus
are apparent. First, no two family members have the same
expression pattern even when complete temporal and spa-
tial data are examined. Second, most genes are expressed
in multiple trophoblast cell subtypes though none were
detected in the chorion, where trophoblast stem cells
reside, or in syncytiotrophoblast of the labyrinth layer.
Third, bioinformatic comparisons of upstream regulatory
regions identified predicted transcription factor binding
site modules that are shared by genes expressed in the
same trophoblast subtype. Fourth, further diversification
of gene products from the PRL/PL locus occurs through
alternative splice isoforms for several genes.
In reviewing the summary data, it was striking that so
many genes within the PRL/PL family are expressed in the
ectoplacental cone and in the adjacent parietal TGCs early
in gestation. It was already reported that TGCs at the
periphery of the ectoplacental cone express Prl3d  and
Prl2c as early as E6.5 [53] and Prl7a1, Prl4a1 and Prl6a1
are expressed in the developing placenta as early as E8.0
[32,54]. Interestingly, PRL/PL family members found at
the periphery of the ectoplacental cone are not uniformly
expressed in all TGCs and likely demarcate distinct TGC
subpopulations and/or stages of TGC differentiation.
Expression of genes in trophoblast cells at the center of the
ectoplacental cone was also diverse. Of note, Prl3b1  is
expressed in a small subset of cells within the center of the
ectoplacental cone at E8.5, possibly in secondary TGC
precursors or spongiotrophoblast precursors. Prl3b1
expression, which is broad later in gestation, has not been
described before E9 at which time Prl3d  expression in
TGCs begins to decline [53]. Prl5a1  expression is also
interesting as it is biphasic in its expression, expressed in
both TGCs and cells in the centre of the ectoplacental
cone early in gestation and not again until late in gesta-
tion where it is expressed in spongiotrophoblast cells. Fur-
ther studies are required to understand the heterogeneous
ectoplacental cone and parietal TGC cell populations.
The current studies have also provided several markers
that are restricted to either the spongiotrophoblast or gly-
cogen cell populations. The junctional zone of the pla-
centa contains both spongiotrophoblast cells and
glycogen trophoblast cells. While many genes are known
to be expressed within this layer [35], there had been very
few genes definitively characterized as markers of either
spongiotrophoblast or glycogen trophoblast cells,
although members of the PRL/PL family (Prl2a1, Prl7b1 in
mouse and Prl4a1, Prl2a1, Prl7b1 and Prl5a1 in rat) have
been specifically localized to invasive/migratory trophob-
last within the decidua [55], suggesting 'migratory' or gly-
cogen trophoblast specificity. Pcdh12  [44,45] and
connexin 31 [56] have been recently identified as glyco-
gen trophoblast cell-specific markers, but no spongiotro-
phoblast-specific markers have been reported. Double in
situ hybridization with PRL/PL  family members and
Pcdh12 showed that expression of Prl3b1, Prl2c, Prl8a6,
Prl8a8,  Prl8a1,  Prl7a2,  Prl3a1,  Prl2b1, and Prl5a1  is
restricted to spongiotrophoblast cells. Prl8a8 appears to
be the best spongiotrophoblast-specific marker as it is not
expressed in any other trophoblast cell subtypes through-
out gestation and appears to be broadly expressed within
the entire population of spongiotrophoblast. In contrast,
Prl6a1, Prl2a1, Prl7b1 and Prl7c1 all have expression pat-
terns overlapping with Pcdh12  expression (or comple-
mentary to Prl7a2  as shown) indicating they are
specifically expressed in glycogen trophoblast cells within
this layer. Markers that allow the distinction of glycogen
trophoblast and spongiotrophoblast cells will be very use-
ful in dissecting the pathology of mouse mutants with pla-
cental phenotypes, since the most commonly used
marker, Tpbpa, is expressed in both [46]. It is also unclear
whether glycogen trophoblast cells differentiate directlyBMC Genomics 2008, 9:352 http://www.biomedcentral.com/1471-2164/9/352
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Expression of numerous PRL/PL family members within the ectoplacental cone Figure 3
Expression of numerous PRL/PL family members within the ectoplacental cone. In situ hybridization of PRL/PL fam-
ily members in E8.5 implantations sites. Black boxes represent the area magnified in the image below. Dec – decidua, EPC – 
ectoplacental cone. Black bar represents 1.5 mm. Red bar represents 100 μm.
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Spongiotrophoblast and glycogen trophoblast expression of PRL/PL family members Figure 4
Spongiotrophoblast and glycogen trophoblast expression of PRL/PL family members. A – Double in situ hybridiza-
tion of Pcdh12 (Blue) and Prl7a2 (Brown) in E14.5 placenta. B – Double in situ hybridization of Prl6a1 (Blue) and Prl7a2 (Brown) 
in E14.5 placenta. C – Summary of spongiotrophoblast and glycogen trophoblast-specific expression patterns as well as genes 
expressed in both populations.
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Common modules of transcription factor binding sites within the promoters of commonly expressed PRL/PL family members Figure 5
Common modules of transcription factor binding sites within the promoters of commonly expressed PRL/PL 
family members. A – 3000 bases upstream of the coding sequence plus 200 bases within the coding sequence of 5 genes that 
are expressed within the glycogen trophoblast population. B – 3000 bases upstream of the coding sequence plus 200 bases 
within the coding sequence of 3 genes that are expressed within the sinusoidal TGC population within the labyrinth. Examples 
of 2 different modules are shown.
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Several PRL family members have multiple splice variants Figure 6
Several PRL family members have multiple splice variants. The splice patterns of both the originally reported tran-
scripts and their predicted novel isoforms are depicted on the left. Arrows indicate the location and direction of PCR primers 
used to verify expression of each isoform. Arrow heads (>) indicate the direction of transcription. * indicates predicted tran-
script. Gel pictures showing PCR amplicons for all the isoforms with the corresponding fragment sizes are shown on the right.
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from spongiotrophoblast later in gestation [46] or
whether they represent an independent trophoblast pop-
ulation earlier within the ectoplacental cone [44]. Exam-
ining both spongiotrophoblast and glycogen trophoblast
in mutant mice with defects in the junctional zone will
give insights into this question.
Gaining a better understanding of the regulation of gene
expression from the PRL/PL locus was also a major aim of
our study. Placental-specific expression from the
expanded human growth hormone locus is regulated by a
locus control region 15–32 kb upstream of the gene clus-
ter [26,27]. The evidence to date has not generally sup-
ported the notion that the rodent PRL/PL  genes are
similarly regulated; small defined upstream regions iso-
lated from the promoters of several PRL/PL family mem-
bers, including rat Prl3b1 (Pl2) [57-59], mouse Prl3d (Pl1)
[60-62] and Prl2c (Plf) [60], rat Prl4a1 (Plp-A) [63], rat
Prl8a2 (d/tPrp) [64], rat Prl8a3 (Plp-Cv) [65], independ-
ently drive trophoblast-specific expression in vitro. Fur-
thermore, genes with similar placental expression patterns
do not appear to be grouped together within the PRL/PL
cluster [2,4]. Nevertheless, regulatory elements for Prl3b1
[66] and Pl3d and Prl2c (J.C. Cross, unpublished data)
that are sufficient in vitro fail to drive trophoblast-specific
expression when tested in vivo. This indicates a require-
ment for additional elements for these genes at least mak-
ing it difficult to rule out completely the involvement of
locus control regions or additional enhancers. In addi-
tion, complete temporal and spatial expression data for
each PRL/PL family member have not been compiled. In
the current study we compiled expression data for each
family member over the whole time course of placenta-
tion with high resolution, reporting expression patterns in
all the characterized trophoblast subtypes, in an effort to
uncover unappreciated associations between locus posi-
tion and expression patterns. The identification of regula-
tory elements driving trophoblast subtype-specific gene
expression would be of particular use for future studies of
trophoblast differentiation and placental development. It
is now clear from our data set however that each PRL/PL
family member has a truly unique expression pattern with
no correlation to locus structure, consistent with previous
reports [2,4] and diminishing further the likelihood of
control regions driving subtype-specific trophoblast
expression. As such, subtype-specific expression patterns
are likely driven by elements contained within the local
upstream promoters of individual genes, although this
does not preclude the possibility of a locus control region
regulating placental-specific for the entire cluster, regulat-
ing trophoblast-specific transcriptional access to the
whole of the region.
We therefore sought another way to investigate trophob-
last subtype-specific regulatory elements. Previous studies
of PRL/PL gene regulation have rarely investigated what, if
any, subtype-specific expression is conveyed by the iden-
tified elements. Two notable exceptions are an enhancer
element from the rat Prl8a3  promoter shown to drive
expression preferentially in spongiotrophoblast cells
rather than TGCs [65] and the demonstration that the
transcription factor Gata2 is essential to restrict Prl4a1
expression to secondary TGCs within the TGC population
[67]. We used the bioinformatics software program
Toucan2 [37] to identify groups, or modules, of putative
transcription factor binding sites present in multiple pro-
moter sequences from genes co-expressed in a particular
trophoblast subtype, rather than a single promoter in iso-
lation. This approach effectively narrows the focus to ele-
ments involved in gene expression within a particular cell
population, rather than trophoblast specificity in general.
Our comprehensive expression data set allowed us for the
first time to try such an in silico approach and we com-
pared the promoters of genes co-expressed in the poorly
characterized glycogen trophoblast and sinusoidal TGC
populations as examples, identifying several modules of
putative transcription factor binding sites common to the
promoters of each group. The identification of these con-
served modules serves not only to bolster the notion of
local versus distant regulation of PRL/PL family members,
but provides a valuable in silico resource to identify can-
didate elements for further experimental studies. Interest-
ingly, putative Gata3 sites were identified in all the
modules, a factor of known importance for trophoblast-
specific expression of Prl3d and Prl2c [60-62]. Also, puta-
tive AP-1 sites were present in both modules contained in
the promoters of genes co-expressed in glycogen trophob-
last cells, motifs important for Plr3d and Plr3b1 expression
[59,62]. The presence of motifs previously been shown to
play roles in regulating trophoblast-specific PRL/PL mem-
bers within the modules imparts a higher degree of confi-
dence to these predicted elements, making them strong
candidates for further experimental studies.
We conducted our expression analysis in three different
mouse lines, not only to increase the confidence of our
data set but also to investigate whether any PRL/PL family
members are expressed differently between commonly
used strains. We chose the outbred stock CD-1 and two
inbred strains C57/B6 and 129svj, all commonly used
lines. Average litter sizes are known to vary among differ-
ent mouse stocks and strains (129svj – average 4.5 pups/
litter [68], C57/B6 – average 6.2 pups/litter [68], CD-1 –
average 11 pups/litter (Charles River) and several PRL/PL
family members have been shown to regulate reproduc-
tive adaptations to physiological stresses such as hypoxia.
Differences in PRL/PL gene expression between lines may
therefore be related to differences in litter size and the
accompanying changes in physiological adaptation [69].
Interestingly, only a few slight differences in the timing ofBMC Genomics 2008, 9:352 http://www.biomedcentral.com/1471-2164/9/352
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PRL/PL  family expression or the breadth of expression
within a certain trophoblast subtype were observed.
Gene duplication followed by the acquisition of novel
gene function offers a way for species to adapt to changing
environmental challenges or to capitalize on newly avail-
able niches. Interestingly, members of the murine PRL/PL
family have undergone further diversification by adopting
splice variants. Evidence for positive selection within large
families of amplified genes, particularly those associated
with reproduction, has been accumulating [70-74]. One
theory suggests that the gene duplication event itself is
positively selected for to allow the amplification of genes
that are somewhat pre-adapted to meet a particular envi-
ronmental challenge or biochemical niche, so that diver-
gence and acquisition of new functionality may follow
[75]. It is tempting to visualize the evolution of the PRL/
PL genes in rodents and ruminants as a result of the driv-
ing environmental challenge of reproductive fitness.
Numerous other gene families have been reported in the
mouse genome that are also associated with reproduction
such as the placentally expressed cathepsins [76-78], Rhox
transcription factors [79] and pregnancy-specific glyco-
proteins [80,81], although their specific roles in reproduc-
tion remain largely unknown. The functions of the
individual PRL/PL family members are just beginning to
be revealed through knockout mouse studies. The diverse
patterns of expression and evidence of splice variants indi-
cates that the family is rapidly evolving and suggests that
the different genes have distinct functions. The majority of
PRL/PL genes are expressed later in gestation when it is
likely they are acting as hormones to affect feto-maternal
adaptations to pregnancy, but it is also apparent from this
study that approximately half of the PRL/PL family mem-
bers are expressed early in the ectoplacental cone and may
be involved in decisions affecting cell fate. Whether the
PRL/PL locus evolved as a result of positive selection, or
some other adaptive force, it is now clear that PRL/PL gene
amplification serves as an excellent model for studying
the process of genetic diversification.
Conclusion
The gene expression data in this study clearly demon-
strates that no two PRL/PL family members share the
same temporal and spatial expression pattern. It is now
very clear that there is no correlation in expression
between genes that are most closely related or between
adjacent genes in the PRL/PL locus. Bioinformatic analysis
of upstream regulatory regions identified conserved mod-
ules of putative transcription factor binding sites shared
by genes expressed in the same trophoblast subtype. Inter-
estingly, we have also observed that although mouse PRL/
PL genes are expressed in multiple trophoblast subtypes,
no family members were detected in the chorion, where
trophoblast stem cells reside, or in syncytiotrophoblast of
the labyrinth layer. The information gleaned in this study
has also identified novel markers that will provide valua-
ble insight into mouse models with placental phenotypes.
Additionally, we have observed for the first time that
approximately half of the PRL/PL genes are expressed
early in the ectoplacental cone and may be involved in
decisions affecting cell fate. Based on our findings, we pro-
pose that the PRL/PL gene family represents an excellent
model for studying the process of genetic diversification.
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Additional file 2
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for the Prl3d genes.
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Additional file 3
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl3c1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-352-S3.pdf]
Additional file 4
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl3b1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-352-S4.pdf]
Additional file 5
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl3a1.
Click here for file
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Additional file 6
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl6a1.
Click here for file
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2164-9-352-S6.pdf]
Additional file 7
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl8a2.
Click here for file
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Additional file 8
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl2b1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-352-S8.pdf]
Additional file 9
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl8a6.
Click here for file
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2164-9-352-S9.pdf]
Additional file 10
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl8a8.
Click here for file
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Additional file 11
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl8a9.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-352-S11.pdf]
Additional file 12
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl8a1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-352-S12.pdf]
Additional file 13
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl7b1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-352-S13.pdf]
Additional file 14
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl7a1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-352-S14.pdf]
Additional file 15
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl7a2.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-352-S15.pdf]
Additional file 16
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl7d1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-352-S16.pdf]
Additional file 17
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl7c1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-352-S17.pdf]
Additional file 18
A – In situ hybridizations of early (E8.5) and mid to late gestation 
(E12.5, E14.5, or E18.5) placenta for each member of the PRL/PL fam-
ily. Higher magnifications emphasize particular trophoblast subtypes 
including parietal TGCs, spiral artery TGCs, canal TGCs, sinusoidal 
TGCs, spongiotrophoblast, glycogen trophoblast cells, and decidua. B – 
Temporal gene expression data (based in situ hybridization signals) for 
individual placental cell types. Shades of grey depict an estimation of the 
percentage of each cell type that expresses the gene. White – 0%, Light 
grey ~25%, Medium Grey ~50%, Dark grey ~75%, Black > 75%. Sum-
mary of in situ hybridization data for Prl2a1.
Click here for file
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